Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 206589
Company: AUROBINDO PHARMA LTD
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
POLYMYXIN B SULFATE POLYMYXIN B SULFATE EQ 500,000 UNITS BASE/VIAL INJECTABLE;INJECTION Prescription AP No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
04/04/2016 ORIG-1 Approval STANDARD

Label is not available on this site.

POLYMYXIN B SULFATE

INJECTABLE;INJECTION; EQ 500,000 UNITS BASE/VIAL
TE Code = AP

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
POLYMYXIN B SULFATE POLYMYXIN B SULFATE EQ 500,000 UNITS BASE/VIAL INJECTABLE;INJECTION Prescription No AP 206589 AUROBINDO PHARMA LTD
POLYMYXIN B SULFATE POLYMYXIN B SULFATE EQ 500,000 UNITS BASE/VIAL INJECTABLE;INJECTION Prescription No AP 065372 FRESENIUS KABI USA
POLYMYXIN B SULFATE POLYMYXIN B SULFATE EQ 500,000 UNITS BASE/VIAL INJECTABLE;INJECTION Prescription No AP 207322 GLAND PHARMA LTD
POLYMYXIN B SULFATE POLYMYXIN B SULFATE EQ 500,000 UNITS BASE/VIAL INJECTABLE;INJECTION Prescription No AP 090110 MYLAN ASI
POLYMYXIN B SULFATE POLYMYXIN B SULFATE EQ 500,000 UNITS BASE/VIAL INJECTABLE;INJECTION Prescription No AP 063000 X GEN PHARMS
POLYMYXIN B SULFATE POLYMYXIN B SULFATE EQ 500,000 UNITS BASE/VIAL INJECTABLE;INJECTION Prescription No AP 202766 XELLIA PHARMS APS

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English